Sonoma Pharmaceuticals, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP

83558L204
SEDOL

N/A
CIK

0001367083

www.sonomapharma.com
LEI:
FIGI: BBG000M75YR0
SNOA

Sonoma Pharmaceuticals, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Drug Manufacturers—Specialty & Generic
NAME
Sonoma Pharmaceuticals, Inc.
ISIN
US83558L2043
TICKER
SNOA
MIC
XNAS
REUTERS
SNOA.OQ
BLOOMBERG
SNOA US
GIF DE 728x90
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von AccesWire bereitgestellt.
Do., 21.11.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, an...
Mo., 11.11.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, an...
Do., 07.11.2024       Sonoma Pharmaceuticals
US83558L2043

Revenue increased 31% for the quarter compared to same period prior yearPositive cash flows from operations of $0.35 million for the quarterNet loss improved 59% for the quarter compared to same period prior yearNet loss per share improved 90% for the quarter compared to same period prior year BOULDER, CO / ACCESSWIRE / November 7, 2024 / Sonoma Ph...
Do., 31.10.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / October 31, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, an...
Di., 22.10.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / October 22, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and...
Mo., 21.10.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / October 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and...
Do., 19.09.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / September 19, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, a...
Di., 17.09.2024       Sonoma Pharmaceuticals
US83558L2043

BOULDER, CO / ACCESSWIRE / September 17, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, a...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements